After moving -2.4% during today's afternoon session, Albemarle is now trading at a price of $155.96 per share. On average, analysts give it a target price of $261.46.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide.
Albemarle Investors Should Consider This:
-
Albemarle has moved -44.0% over the last year.
-
The company has a price to earnings growth (PEG) ratio of 0.48. A number between 0 and 1 could mean that the market is undervaluing Albemarle's estimated growth potential
-
Its Price to Book (P/B) ratio is 1.86
-
Albemarle currently returns an annual dividend yield of 1.0%.
Understanding Albemarle's Operating Margins
| Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-15 | 7,320,104 | -596,126 | 34 | 126.67 |
| 2022-02-22 | 3,327,957 | -495,508 | 15 | -6.25 |
| 2021-02-19 | 3,128,909 | -489,041 | 16 | -15.79 |
| 2020-04-15 | 3,589,427 | -591,655 | 19 | -9.52 |
| 2019-02-27 | 3,374,950 | -516,144 | 21 | 10.53 |
| 2018-02-28 | 3,071,976 | -522,231 | 19 |
Over the last 6 years, Albemarle's operating margins have averaged 20.7%, which is better than the 13.05% Chemicals industry average. We also note that the company's operating margins have a high coefficient of variability at 33.3%. In addition, the firm's margins benefit from a 10.1% yearly growth rate.
